Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Director Dealing, Option Exercise & TVR

13 May 2021 07:00

RNS Number : 4551Y
finnCap Group PLC
13 May 2021
 

13 May 2021

 

 

finnCap Group plc

Director Dealing, Option Exercise and Total Voting Rights

finnCap Group plc (AIM: FCAP) (the "Company") today announces that Stuart Andrews, an executive director of the Company, has exercised options over 1,100,000 ordinary shares at a price of 14p per share under the finnCap EMI Plan.

Following the exercise of these options, Stuart Andrews has a beneficial interest in 4,978,334 ordinary shares, representing 2.82% of the Company's issued share capital, and has further options over 1,100,000 ordinary shares.

The Company's Ordinary Shares referred to above are finnCap Group plc ordinary shares of 1 penny each and, following the issue of these 1,100,000 shares and the additional issue of shares to another employee who has exercised his options, the total number of shares in issue is 176,585,014.

Further details on the exercise are included in the notifications below, made in accordance with the requirements of the EU Market Abuse Regulation which is part of English law by virtue of the European Union (Withdrawal) Act 2018.

Contacts

finnCap Group plc Tel: +44 (0) 20 7220 0500

Sam Smith, Chief Executive Officer investor.relations@finncap.com

Richard Snow, Chief Financial Officer

Grant Thornton (Nominated Adviser) Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/George Grainger

Oberon Capital (Joint Broker) Tel: +44 (0) 20 3179 5344

Mike Seabrook

finnCap Ltd (Joint Broker) Tel: +44 (0) 20 7220 0500

Rhys Williams/Tim Redfern

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stuart Andrews

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director, Managing Director of finnCap

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

finnCap Group plc

b)

 

LEI

 

 

213800DLRUJW6JVNS533

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

 

 

Identification code

GB00BGKPX309

 

 

b)

 

Nature of the transaction

 

 

Exercise of options pursuant to the finnCap EMI Plan

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

£0.14

1,100,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

12 May 2021

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCGDUBGBDGBD
Date   Source Headline
19th Oct 20227:15 amRNSRule 2.9 Announcement
18th Oct 20222:58 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re finnCap plc
18th Oct 20227:00 amRNSResponse to offer speculation
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20227:00 amRNSDirectorate Change
15th Sep 202211:16 amRNSResult of AGM
15th Sep 20227:00 amRNSAGM Trading Update
1st Sep 20227:00 amRNSCEO Transition Completed
1st Sep 20227:00 amRNSTotal Voting Rights
5th Aug 20227:00 amRNSDividend Declaration, Annual Report & AGM Notice
1st Aug 20227:00 amRNSTotal Voting Rights
14th Jul 20227:00 amRNSResults for year ended 31 March 2022
8th Jul 20227:00 amRNSAppointment of Executive Directors
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSProposed New CEO and appointment of new Directors
1st Jun 20227:00 amRNSBlock Admission Return and Total Voting Rights
16th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
28th Apr 20227:00 amRNSBuilding a leading advisory business
14th Apr 20227:23 amRNSFY22 Unaudited Revenue
1st Apr 20227:00 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTrading Update
1st Mar 20227:00 amRNSTotal Voting Rights
8th Feb 20229:18 amRNSDirector Dealing
1st Feb 20227:00 amRNSTotal Voting Rights
28th Jan 202210:22 amRNSHolding(s) in Company
28th Jan 202210:21 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSOption Exercise, Dealing Amendment and TVR
25th Jan 20227:00 amRNSAppointment of Non-Executive Director
31st Dec 20217:00 amRNSTotal Voting Rights
9th Dec 20215:25 pmRNSHolding(s) in Company
8th Dec 20214:04 pmRNSCOVID Option Exercises and EBT Holdings in Company
1st Dec 20217:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 20217:00 amRNSInterim Results and Dividend
2nd Nov 20217:00 amRNSNotice of Interims and Investor Presentation
1st Nov 20217:00 amRNSTotal Voting Rights
19th Oct 202111:01 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSH1 22 Unaudited Revenues – strong growth on H1 21
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
23rd Sep 202111:21 amRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Trading Statement
15th Sep 20219:51 amRNSAGM Update
1st Sep 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSSecond Interim Dividend
7th Jul 202110:00 amRNSAnnual Report and Annual General Meeting Notice
6th Jul 20217:00 amRNSDirector Dealing, Option Exercise and TVR
1st Jul 20217:00 amRNSPreliminary results - year ended 31 March 2021
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.